首页> 外文期刊>Quality Control, Transactions >MedGlasses: A Wearable Smart-Glasses-Based Drug Pill Recognition System Using Deep Learning for Visually Impaired Chronic Patients
【24h】

MedGlasses: A Wearable Smart-Glasses-Based Drug Pill Recognition System Using Deep Learning for Visually Impaired Chronic Patients

机译:Medglasses:一种使用深层学习的可穿戴智能眼镜的药丸识别系统,用于视力受损的慢性患者

获取原文
获取原文并翻译 | 示例
       

摘要

Today, with the arrival of an aging society, the average age of the population is rising. It is known that the physiology of a person degrades with age. There are approximately 285 million visually impaired people in the world, of whom 140 million are elderly people over the age of 50, and 110 million of these visually impaired elderly people suffer from multiple chronic diseases. In the case of multiple medication usage, these 110 million vulnerable people will be more likely to take the wrong medicines or forget to take their medication. To solve this problem, this paper proposes a wearable smart-glasses-based drug pill recognition system using deep learning, named MedGlasses, for visually impaired people to improve their medication-use safety. The proposed MedGlasses system consists of a pair of wearable smart glasses, an artificial intelligence (AI)-based intelligent drug pill recognition box, a mobile device app, and a cloud-based information management platform. Experimental results show that a recognition accuracy of up to 95.1 & x0025; can be achieved. Therefore, the proposed MedGlasses system can effectively mitigate the problem of drug interactions caused by taking incorrect drugs, thereby reducing the cost of medical treatment and providing visually impaired chronic patients with a safe medication environment.
机译:今天,随着年迈的社会到来,人口的平均年龄正在上升。众所周知,人的生理学随着年龄的增长而劣化。世界上有大约2.85亿千万百万人,其中14亿人民是50岁以上的老年人,其中1.1亿岁的老年人患有多种慢性疾病。在多种药物用途的情况下,这些1.1亿脆弱的人将更有可能采取错误的药物或忘记服用药物。为了解决这个问题,本文提出了一种使用深层学习的可穿戴智能眼镜的药丸识别系统,名叫中墨片,用于视障人士,以改善其药物使用安全性。该拟议的Medglasses系统包括一对可穿戴智能眼镜,人工智能(AI)基础的智能药丸识别箱,移动设备应用程序和基于云的信息管理平台。实验结果表明,识别准确性高达95.1&x0025;可以实现。因此,所提出的中介系统可以有效地减轻通过采取不正确的药物引起的药物相互作用的问题,从而降低了治疗的成本,并提供了安全药物环境的视力受损慢性患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号